Biotricity, Inc. (BTCY)

Market Cap	9.21M
Revenue (ttm)	12.24M
Net Income (ttm)	-18.28M
Shares Out	23.02M
EPS (ttm)	-1.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,448
Open	0.400
Previous Close	0.370
Day's Range	0.363 - 0.441
52-Week Range	0.186 - 1.670
Beta	1.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City,...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Waqaas Al-Siddiq
• Employees: 55
• Stock Exchange: OTCMKTS
• Ticker Symbol: BTCY

Financial Performance

In 2023, Biotricity's revenue was $12.06 million, an increase of 25.15% compared to the previous year's $9.64 million. Losses were -$14.93 million, -23.57% less than in 2022.